Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Knowing when to start a retirement plan is crucial for maximizing your savings. Explore the best timing for a secure financial future.
20,372 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Oklo is developing compact nuclear reactors geared for AI data centers. This article lays out a grounded five-year ro...
A new nonprofit, Ethereum Institutional, launches to act as a neutral entry point for institutions exploring Ethereum...
AppLovin stock has been moving decisively higher this week. Learn the catalysts, what the move signals for investors,...
When a top executive sells shares, investors tune in. This article breaks down what a recent move by Ladder Capital's...
As AI demand accelerates, investors wonder if Micron Technology can become Nvidia. This practical guide breaks down t...
Joby Aviation stock trades near multi-month lows as investors weigh FAA milestones, manufacturing scale, and internat...
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Figma posted impressive numbers in early 2026, yet the stock slumped. This article breaks down the drivers behind fig...
SpaceX, Rocket Lab, and AST SpaceMobile retreat as a China rocket milestone and an oil price spike pressure space-sto...
July brings a tech-driven reshuffle in enterprise budgets. IBM warned of softer Q2 demand as clients pivot toward AI ...
J.B. Hunt Transport Services heads into tonight's Q2 print trading up about 41% for the year. Analysts will be listen...